Ceftolozán/tazobaktám (Hungarian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Ceftolozán/tazobaktám" in Hungarian language version.

refsWebsite

Global rank Hungarian rank

2^nd place

8^th place

5^th place

22^nd place

1web.archive.org

1^st place

1^st place

447^th place

591^st place

1tandfonline.com

507^th place

831^st place

274^th place

438^th place

doi.org

dx.doi.org

Long, Timothy E (2014. október 1.). „Cephalosporins currently in early clinical trials for the treatment of bacterial infections” (angol nyelven). Expert Opinion on Investigational Drugs 23 (10), 1375–1387. o. DOI:10.1517/13543784.2014.930127. ISSN 1354-3784.
Zhanel, George G., Heather (2014. január 1.). „Ceftolozane/Tazobactam: A Novel Cephalosporin/β-Lactamase Inhibitor Combination with Activity Against Multidrug-Resistant Gram-Negative Bacilli” (angol nyelven). Drugs 74 (1), 31–51. o. DOI:10.1007/s40265-013-0168-2. ISSN 0012-6667.
(2019. február 27.) „Human medicines European public assessment report (EPAR): Zerbaxa, ceftolozane / tazobactam, Bacterial Infections, Date of authorisation: 18/09/2015, Revision: 8, Status: Authorised”. Case Medical Research. DOI:10.31525/cmr-c543de. ISSN 2643-4652.
Moya, B., C. (2010. június 14.). „Affinity of the New Cephalosporin CXA-101 to Penicillin-Binding Proteins of Pseudomonas aeruginosa”. Antimicrobial Agents and Chemotherapy 54 (9), 3933–3937. o. DOI:10.1128/aac.00296-10. ISSN 0066-4804.
Bounthavong, Mark, Mai-Chi (2013. november 1.). „Ceftolozane/tazobactam: a novel antipseudomonal cephalosporin and β-lactamase-inhibitor combination”. Infection and Drug Resistance, 215. o. DOI:10.2147/idr.s36140. ISSN 1178-6973.
Takeda, S., Y. (2006. december 4.). „In Vitro and In Vivo Activities of a New Cephalosporin, FR264205, against Pseudomonas aeruginosa”. Antimicrobial Agents and Chemotherapy 51 (3), 826–830. o. DOI:10.1128/aac.00860-06. ISSN 0066-4804.

fda.gov

FDA approves new antibacterial drug Zerbaxa. web.archive.org, 2015. május 9. [2015. május 9-i dátummal az eredetiből archiválva]. (Hozzáférés: 2019. július 2.)

springer.com

link.springer.com

Zhanel, George G., Heather (2014. január 1.). „Ceftolozane/Tazobactam: A Novel Cephalosporin/β-Lactamase Inhibitor Combination with Activity Against Multidrug-Resistant Gram-Negative Bacilli” (angol nyelven). Drugs 74 (1), 31–51. o. DOI:10.1007/s40265-013-0168-2. ISSN 0012-6667.

tandfonline.com

Long, Timothy E (2014. október 1.). „Cephalosporins currently in early clinical trials for the treatment of bacterial infections” (angol nyelven). Expert Opinion on Investigational Drugs 23 (10), 1375–1387. o. DOI:10.1517/13543784.2014.930127. ISSN 1354-3784.

web.archive.org

FDA approves new antibacterial drug Zerbaxa. web.archive.org, 2015. május 9. [2015. május 9-i dátummal az eredetiből archiválva]. (Hozzáférés: 2019. július 2.)

worldcat.org

Long, Timothy E (2014. október 1.). „Cephalosporins currently in early clinical trials for the treatment of bacterial infections” (angol nyelven). Expert Opinion on Investigational Drugs 23 (10), 1375–1387. o. DOI:10.1517/13543784.2014.930127. ISSN 1354-3784.
Zhanel, George G., Heather (2014. január 1.). „Ceftolozane/Tazobactam: A Novel Cephalosporin/β-Lactamase Inhibitor Combination with Activity Against Multidrug-Resistant Gram-Negative Bacilli” (angol nyelven). Drugs 74 (1), 31–51. o. DOI:10.1007/s40265-013-0168-2. ISSN 0012-6667.
(2019. február 27.) „Human medicines European public assessment report (EPAR): Zerbaxa, ceftolozane / tazobactam, Bacterial Infections, Date of authorisation: 18/09/2015, Revision: 8, Status: Authorised”. Case Medical Research. DOI:10.31525/cmr-c543de. ISSN 2643-4652.
Moya, B., C. (2010. június 14.). „Affinity of the New Cephalosporin CXA-101 to Penicillin-Binding Proteins of Pseudomonas aeruginosa”. Antimicrobial Agents and Chemotherapy 54 (9), 3933–3937. o. DOI:10.1128/aac.00296-10. ISSN 0066-4804.
Bounthavong, Mark, Mai-Chi (2013. november 1.). „Ceftolozane/tazobactam: a novel antipseudomonal cephalosporin and β-lactamase-inhibitor combination”. Infection and Drug Resistance, 215. o. DOI:10.2147/idr.s36140. ISSN 1178-6973.
Takeda, S., Y. (2006. december 4.). „In Vitro and In Vivo Activities of a New Cephalosporin, FR264205, against Pseudomonas aeruginosa”. Antimicrobial Agents and Chemotherapy 51 (3), 826–830. o. DOI:10.1128/aac.00860-06. ISSN 0066-4804.